The presymptomatic phase of type 1 diabetes is marked by the presence of two or more islet autoantibodies, classified into ...

NASHVILLE, Tenn. ( WSMV /Gray News) - For the first time in more than a hundred years, there’s now an FDA-approved ...

CVS Caremark has removed several therapies to treat patients with diabetes in favor of newer products and generics, and is ...

A new treatment is changing the lives of those with early onset Type 1 Diabetes. A new drug approved by the Food and Drug ...

The clearance allows the system to offer personalised insights for individuals managing diabetes through MDI therapies.

Three-fourths of U.S. adults are now overweight or have obesity, with nearly 260 million predicted to have overweight or ...

Doctors Without Borders, also known as Médecins Sans Frontières (MSF), and organisations representing people with diabetes ...

The best microscopes for kids allow children to discover the world in miniature. As these naturally curious little scientists journey around the big wide world we see them inevitably become ...

AstraZeneca and Amgen announced that a Phase 3 trial of Tezspire (tezepelumab) showed a statistically significant and ...

has announced its donation of several insulin pumps to children with type 1 diabetes who are receiving treatment at the Diabetes Clinic in Salmaniya Medical Complex, part of the government hospitals.

Novo Nordisk is phasing out human insulin pens to focus on its newer diabetes and obesity medicines, sparking protests and concerns over access in low-income countries. Modern insulin, preferred in ...

Novo Nordisk is gradually ending production of human insulin pens, a spokesperson confirmed to Reuters. Instead, the company is channeling investments into manufacturing its popular obesity and ...